Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,135.95
(
-0.04%
)
US TECH 100
26,646.40
(
1.31%
)
Dow Jones
48,861.81
(
-0.57%
)
Brent Oil
111.57
(
-0.72%
)
Bitcoin
76,174.00
(
0.52%
)
News Focus
News Focus
Post# of 257470
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122909
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 254174

Thursday, 02/06/2025 5:58:13 PM

Thursday, February 06, 2025 5:58:13 PM

Post# of 257470
ALMS acquires SLRN for $2.35/sh* in stock—a 24% premium to today’s 4:00pm closing price:

https://www.globenewswire.com/news-release/2025/02/06/3022460/0/en/Alumis-and-ACELYRIN-to-Merge-Creating-a-Late-Stage-Clinical-Biopharma-Company-Dedicated-to-Innovating-Developing-and-Commercializing-Transformative-Therapies-for-Immune-mediated-Di.html

*Based on SLRN’s AH price of $5.51 (as I’m typing). The exchange ratio is 0.4274 shares of ALMS for each share of SLRN.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today